FDA Warning Letter — Algunas Inc., dba Woodland Hills Compounding Pharmacy
The FDA took a Warning Letter action against Algunas Inc., dba Woodland Hills Compounding Pharmacy on July 17, 2017 (Woodland Hills, CA). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Algunas Inc., dba Woodland Hills Compounding Pharmacy
- Date
- July 17, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Woodland Hills, CA (United States)